FDA daily for Tuesday, April 21, 2026
In this issue: 2 shortage updates, 11 approvals and 22 device decisions.
Drug shortages
FDA date:FDA updated 2 shortage entries on Mon, Apr 20: 2 new, 2 to be discontinued.
- Ketorolac Tromethamine Tablet
Mylan Pharmaceuticals Inc., a Viatris Company
- Rifampin Injection
Sanofi-Aventis U.S. LLC
Drug and biologic approvals
FDA date:On Tue, Apr 14 FDA approved 1 new application (0 brand or biologic, 1 generic) and 10 supplements to existing ones.
- CANAGLIFLOZIN
APOTEX · CANAGLIFLOZIN
Device clearances and approvals
FDA date:FDA decided 14 510(k)s and 8 PMA decisions on Tue, Apr 7.
- Momcozy Wearable Breast Pump (S9 Pro, S9 Pro-A, S9 Pro-B, S9 Pro-C, S9 Pro-D, S9 ProY-A, S9 ProY-B, S9 ProY-C, S12 Pro, S12 Pro-A, S12 Pro-B, S12 Pro-C, S12 Pro-D, S12 ProY-A, S12 ProY-B, S12 ProY-C)
Shenzhen Root Innovation Technology Co., Ltd. · Obstetrics/Gynecology
- IWD-Gel
InnovaCorium, Inc. · Unknown
- ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040)
Anumana, Inc. · Cardiovascular
- Multifunctional Operational Dissectors (Electrosurgical Pencils);Multifunctional Operational Dissectors (Disposable Electrode)
Zhejiang shuyou Surgical Instrument Co., Ltd. · General, Plastic Surgery
- Elecsys Anti-HBc IgM
Roche Diagnostics · Microbiology
- Elecsys Anti-HAV IgM
Roche Diagnostics · Microbiology
- Warming System
Hangzhou Tappa Medical Technology Co., Ltd. · Cardiovascular
- Firefighter Pro PTCA Balloon Catheter
Shanghai MicroPort Medical (Group) Co., Ltd. · Cardiovascular
- PrimeSight UltraView System
Cogentix Medical, Inc. · Gastroenterology, Urology
- Voyager DSLT (430840610)
Belkin Vision, Ltd. · Ophthalmic
- AuST Steerable Sheath
CenterPoint Systems, LLC · Cardiovascular
- Powder Free Synthetic Vinyl Exam Gloves (Blue, Black)
Basic Medical Technology, Inc. · General Hospital
- Power Wheelchair (OS-R-M01S)
Beijing OrionStar Technology Co., Ltd. · Physical Medicine
- Elecsys Anti-HBc II
Roche Diagnostics · Microbiology
FDA did not answer for Drug recalls, Labels, Device recalls, Food and supplement recalls while this issue was written; those sections will fill in on a later visit.
How the FDA daily is written
Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.
Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.
